Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma screening: current trends, economic issues, technology, and challenges.

Constance Nduaguba1, Richard K Lee

  • 1Scheie Eye Institute, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

Current Opinion in Ophthalmology
|March 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central subfield thickness changes and factors associated with OCT-confirmed cystoid macular edema after slow-coagulation transscleral cyclophotocoagulation for glaucoma.

International ophthalmology·2026
Same author

Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study.

BMJ open ophthalmology·2026
Same author

Deep Learning-Driven Transmission Electron Microscopy Analysis of Murine Optic Nerve Myelinated Axons.

Ophthalmology science·2026
Same author

Lipidomic dataset of optic nerves from the silicone oil-induced ocular hypertension mouse model.

Data in brief·2026
Same author

Reply to Comment on Association Between Pseudoexfoliation Glaucoma and Central Serous Chorioretinopathy.

American journal of ophthalmology·2026
Same author

Cystoid macular oedema after trabeculectomy versus tube shunt surgery in non-diabetic patients.

BMJ open ophthalmology·2026
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Early detection of glaucoma, a leading cause of irreversible blindness, is crucial. New technologies and public policy initiatives are advancing early diagnosis and treatment, emphasizing the need for increased awareness and improved screening models globally.

Area of Science:

  • Ophthalmology
  • Medical Technology
  • Public Health

Background:

  • Glaucoma is a primary cause of irreversible blindness globally.
  • Early detection and treatment are essential to prevent vision loss from this often asymptomatic condition.

Purpose of the Study:

  • To review advancements in early glaucoma detection technologies.
  • To discuss the role of public policy in addressing glaucoma.
  • To highlight the need for improved glaucoma awareness and screening.

Main Methods:

  • Review of new technologies for optic nerve head, macula, and retinal nerve fiber layer imaging.
  • Evaluation of frequency-doubling technology for visual field loss detection.
  • Analysis of central corneal thickness as a risk factor.

Related Experiment Videos

  • Examination of public policy and legislative efforts for glaucoma screening.
  • Main Results:

    • New imaging technologies offer automated, quantitative measurements for diagnosing optic nerve disease.
    • Frequency-doubling technology shows promise for mass screening of visual field loss.
    • Central corneal thickness is a significant risk factor, impacting traditional screening methods.
    • Public policy initiatives are integrating vision screening into national health agendas.

    Conclusions:

    • Increased glaucoma awareness through education and improved follow-up care are vital.
    • Development of effective screening models for developing countries is necessary to reduce the global burden of glaucoma blindness.